Example: dental hygienist

BIOPHARMACEUTICS CLASSIFICATION SYSTEM

BIOPHARMACEUTICS CLASSIFICATION SYSTEMB asic Absorption and DispositionDrug at Absorption SiteDrug in BodyExcreted DrugMetabolitesabsorptionmetabolismexcre tionClinical Pharmacokinetics, Rowland and Tozer, 2nd Ed, Lea & Febiger, 1989 These models use curve-fitting techniques to estimate kinetic rate constants and other parameters from time-course data for blood, tissue, or excreta; however, the curve-fitted parameters lack biological , J., Pharmac Ther, 12:537-562, 19812 PharmacokineticsDISPOSITION OF DRUGSThe disposition of chemicals entering the body (from Klaassen, Casarett and Doull s Toxicology, 5th ed.)

Apparatus 2 Paddle Tablets, capsules, modified drug products, suspensions Apparatus 3 Reciprocating cylinder Extended-release drug products Apparatus 4 Flow cell Drug products containing low-water-soluble drugs Apparatus 5 Paddle over disk Transdermal drug products Apparatus 6 Cylinder Transdermal drug products

Fullscreen Download

Tags:

Product, Release, Modified

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of BIOPHARMACEUTICS CLASSIFICATION SYSTEM

Documents from same domain

PRINCIPLES OF INTEGRATED AND DISEASE MANAGEMENT …

courseware.cutm.ac.in

Integrated Pest Management (IPM) is a pest management system that, in the context of associated environment and population dynamics of the pest species, utilizes all suitable techniques and methods in as compatible a manner as possible and maintains pest populations at levels below those causing economic injury.

Management, Disease, Step, Integrated, Integrated pest management, Pest management, Integrated and disease management

INTELLECTUAL PROPERTY RIGHTS MCQs

courseware.cutm.ac.in

PCT helps patent offices with their patent granting decisions, and . IPR_B.Sc. Agri. 6th Sem. MCQs Pradipta Banerjee, Ph.D. iii. PCT facilitates public access to a wealth of technical information relating to those inventions a. Only i is correct b. …

Patent

Transformer Differential Protection Setting Calculations

courseware.cutm.ac.in

Differential Protection Setting Calculations Where R CT is CT burden (internal) R W total resistance of the ct secondary wiring. R R is relay burden V S = I (R CT + R W + R R) Where I is the fault current and V S is the ct secondary voltage. In order to make sure that the ct is in the linear range (to avoid ac saturation of the ct’s), V

Protection, Differential, Transformers, Differential protection, Transformer differential protection

Cost Allocation, Apportionment and Absorption of Overheads

courseware.cutm.ac.in

•Allocation is direct process of departmentalization of overheads, where as apportionment needs a suitable basis for sub-division of the cost. •Whether a particular item of expense can be allocated or apportioned does not depends on the nature of expense, but depends on the relation with the cost centre or cost unit to which it is to be ...

Departmentalization

Semisolid Dosage Forms- Ointments, Pastes & Jellies

courseware.cutm.ac.in

wax like substance. It is used to harden or soften ... molecular weights of polyethylene glycol (Macrogols). •PEG are mixture of polycondensation product of ethylene oxide & water. ... •Emulsion bases are more readily miscible with skin secretion compared to …

Emulsion, Polyethylene

3. Preparation & standardization of Sodium Thiosulphate ...

courseware.cutm.ac.in

3. Preparation & standardization of Sodium Thiosulphate Solution- By Ms. Lipsa Samal AIM:To determine the normality of given sample of sodium thiosulphate. REQUIREMENTS: Apparatus : Burette, Volumetric flask, Pipette, Reagents : 0.1 N sodium thiosulphate, Potassium iodate, Potassium iodide. PRINCIPLE: The principle of standardization of sodium thiosulphate is …

Sodium, Sodium thiosulphate, Thiosulphate

CULTURAL CHARACTERISTICS OF MICROORGANISMS

courseware.cutm.ac.in

The semi-solid medium remains in the semi-solid condition. It is prepared by adding small amount of agar (0.5%) or gelatin. Agar is a complex carbohydrates prepared from algae like gelidium and gracillaria. Agar forms a colloidal solution in hot water and sets in the form of a jelly when cool. Gelatin is an animal extract

Microorganism, Agar, Cultural, Characteristics, Cultural characteristics of microorganisms

2. Preparation & standardization of Sulphuric acid (0.1 N ...

courseware.cutm.ac.in

Theory – Sulphuric acid is a diprotic acid and 1 N solution contain 98.08/2 = 49.04 g H2SO4. Taking into consideration specific gravity (1.83) of sulphuric acid about 49.0 ml of conc. Sulphuric acid is required to prepare 1000 ml solution. It is an example of alkalimetry. When a strong acid is titrated with a strong base, the salt produced

Acid, Sulphuric, Sulphuric acid

Guideline on quality of oral modified release products

www.ema.europa.eu

In general, prolonged release oral dosage forms should not have a score line because subdivision or other manipulation of modified release products may adversely affect the modified release properties of the dosage form, possibly leading to dose dumping. Any recommendation on subdivision of a modified release

Product, Release, Modified, Oral, Modified release, Oral modified release products, Modified release products, Release oral

Draft Note Guidance Investigation Bioavailability ...

www.ema.europa.eu

5.1.3.Non-Oral Immediate Release forms with systemic action 13 5.1.4.Modified Release and transdermal dosage forms 13 5.1.5.Fixed combinations products 13 5.1.6.Parenteral solutions 13 5.1.7.Gases 13 5.1.8.Locally applied products 13 5.2. In Vitro Dissolution 14 5.3. Variations 14 5.4. Dose proportionality in immediate release oral dosage forms ...

Product, Release, Modified, Oral, Modified release, Release oral

Annex 7 - WHO

www.who.int

7.1.4 Considerations for modified-release products 146 7.2 Subjects 147 7.2.1 Number of subjects 147 7.2.2 Drop-outs and withdrawals 148 7.2.3 Exclusion of subject data 148 7.2.4 Selection of subjects 148 7.2.5 Monitoring the health of subjects during the study 149 7.2.6 Considerations for genetic phenotyping 149

Product, Release, Modified, Product release